The digital manufacturing marketplace Xometry has reported its strongest quarterly performance to date, sparking enthusiastic investor response. Propelled by unexpectedly robust financial figures and an upgraded outlook, the company’s equity continues to achieve successive record highs. Market participants now question whether this AI-fueled ascent can persist, particularly as the stock has already surpassed most analyst price targets.
Technical Indicators Flash Warning Signs Amid Rally
Market reaction to the earnings report was immediate and powerful: Xometry shares embarked on a dramatic upward trajectory, gaining a remarkable 35 percent within a single week. The surge carried the stock not only past its 52-week peak but also beyond key analyst projections.
However, technical analysis reveals potential concerns. The Relative Strength Index (RSI) currently registers at 81.9, indicating significantly overbought conditions. Extreme volatility measuring 124 percent further underscores market nervousness, raising legitimate questions about whether a consolidation phase may be approaching.
Quarterly Performance Exceeds Projections
Xometry delivered impressive third-quarter 2025 results that substantially outperformed Wall Street expectations. Revenue advanced 28 percent to reach $181 million, while adjusted earnings per share came in at $0.11. Particularly noteworthy was the core Marketplace segment, which posted a 31 percent revenue increase.
Key performance drivers included:
– Active buyers expanded by 21% to exceed 78,000 accounts
– Large accounts spending over $50,000 grew by 14%
– Marketplace gross margin achieved a record 35.7%
Should investors sell immediately? Or is it worth buying Xometry?
Management Boosts Guidance, Fueling Optimism
Demonstrating confidence in future performance, Xometry’s leadership team raised its full-year 2025 forecast. The company now anticipates revenue between $676 million and $678 million. For the fourth quarter, management projects additional substantial growth of 23 to 24 percent.
Despite these operational achievements, Xometry reported a net loss of $11.6 million for the quarter. This contradiction between robust revenue expansion and persistent losses has captured analytical attention.
Analytical Community Divided on Valuation
The investment research community remains split in its assessment. Goldman Sachs increased its price target to $56 while maintaining a “Neutral” rating, whereas JPMorgan adopted a decidedly more optimistic stance with a $70 target and “Overweight” recommendation. Notably, Xometry shares currently trade above the average analyst price target of $63.89.
Some market experts caution about potential overvaluation, suggesting the stock may be trading up to 25 percent above its fair value. This divergence in professional opinion highlights the central investment dilemma: accurately valuing Xometry’s AI-driven growth narrative remains challenging. The critical question for investors is whether the company can continue meeting elevated expectations or if a market correction lies ahead.
Ad
Xometry Stock: Buy or Sell?! New Xometry Analysis from November 10 delivers the answer:
The latest Xometry figures speak for themselves: Urgent action needed for Xometry investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 10.
Xometry: Buy or sell? Read more here...









